Company intelligence / Profile preview

CRI Lifetree

Mount Laurel, New Jersey, United Statesprnewswire.com ↗

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

CRI Lifetree was a leading U.S. contract research organization specializing in early-stage clinical trials with expertise in psychiatry, neurology, pain management, human abuse liability studies, addiction medicine, pediatrics, endocrinology and infectious disease. It operated three major clinics with nearly 200 beds and was recognized for its ability to conduct complex patient population studies including regulatory-required Human Abuse Liability trials for CNS compounds. The company was acquired by PRA Health Sciences in November 2013.

Therapeutic areas: OtherPsychiatryNeurologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on CRI Lifetree.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRI Lifetree.

Explore the full profile